C.R. BARD, INC. (BASD) -3006260740 POWERLOC MAX POWER-INJECTIBLE INFUSION SET 20G X 1.0 IN; SET, ADMINISTRATION, INTRAVASCULAR
|
Back to Search Results |
|
Model Number N/A |
Device Problems
Break (1069); Fluid/Blood Leak (1250); Detachment of Device or Device Component (2907)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 11/12/2023 |
Event Type
malfunction
|
Manufacturer Narrative
|
H11: section a through f: the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The manufacturer has received the sample and will evaluate.Results are expected soon.
|
|
Event Description
|
It was reported by customer via medwatch, "powerloc max 20g 1 inch inserted 2023.Possible lot asgzfc004.Inserted in patient's port, chemo infusing, found completely separated before y port.Chemo and blood spill.This is the 3rd incident with this same product type/lot in 24 hours.This is the fifteenth incident year to date this unit has experiences at hospital.We now stopped using this product.We have made numerous reports to the manufacturer and the fda regarding the integrity of the y-port connection on this product and significant impairment exists.Patient risks infection, blood loss (open line), and leakage of infusate (in these cases it has been chemo)." additional information received 01/16/2024: found completely separated before y-port.Followup: product removed and swapped for power loc (no side port).
|
|
Manufacturer Narrative
|
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The complaint of a break in the infusion set is confirmed; however, the exact cause is unknown.One photograph of a powerloc max was returned for evaluation.An initial visual observation of the photograph showed a 20 g powerloc max which had a disconnection between the tubing and the y-site.Use residue was observed on the sample, and it was also observed that the safety was engaged.There were no distinguishing features in the returned photograph of the device which could aid in identification of a specific root cause.This complaint will be recorded for future trending and monitoring purposes.H3 other text : evaluation findings are in section h11.
|
|
Event Description
|
It was reported by customer via medwatch, "powerloc max 20g 1inch inserted 2023 possible lot asgzfc004.Inserted in patient's port, chemo infusing, found completely separated before y-port.Chemo and blood spill.This is the 3rd incident with this same product type/lot in 24 hours.This is the fifteenth incident year to date this unit has experiences at hospital.We now stopped using this product.We have made numerous reports to the manufacturer and the fda regarding the integrity of the y-port connection on this product and significant impairment exists.Patient risks infection, blood loss (open line), and leakage of infusate (in these cases it has been chemo)." additional information received 01/16/2024: found completely separated before y-port.Follow-up: product removed and swapped for power loc (no side port).
|
|
Manufacturer Narrative
|
H11: section a through f - the information provided by bd represents all of the known information at this time.This complaint was received as part of a clinical survey.Contact information and specific patient details were not disclosed as part of the survey.As such, additional information and the subject sample cannot be obtained.
|
|
Event Description
|
It was reported by customer via medwatch, "powerloc max 20g 1inch inserted 2023 possible lot asgzfc004.Inserted in patient's port, chemo infusing, found completely separated before y-port.Chemo and blood spill.This is the 3rd incident with this same product type/lot in 24 hours.This is the fifteenth incident year to date this unit has experiences at hospital.We now stopped using this product.We have made numerous reports to the manufacturer and the fda regarding the integrity of the y-port connection on this product and significant impairment exists.Patient risks infection, blood loss (open line), and leakage of infusate (in these cases it has been chemo)." additional information received 01/16/2024: found completely separated before y-port.Follow-up: product removed and swapped for power loc (no side port).
|
|
Search Alerts/Recalls
|
|
|